期刊
JACC-CLINICAL ELECTROPHYSIOLOGY
卷 8, 期 6, 页码 722-731出版社
ELSEVIER
DOI: 10.1016/j.jacep.2022.03.007
关键词
KEY WORDS infarct; pulsed field ablation; radiofrequency; swine
资金
- Farapulse, Inc
This study assessed the lesion characteristics of pulsed field ablation (PFA) and radiofrequency energy (RFA) in healthy and infarcted myocardium. The results showed that PFA effectively ablates surviving islands of myocardium and holds promise for treating infarct-related ventricular tachycardia.
BACKGROUND Pulsed field ablation (PFA) leads to cell death by irreversible electroporation. There are limited data about PFA lesion characteristics in the ventricle, particularly in the presence of myocardial scar. OBJECTIVES This study sought to evaluate the lesion characteristics of PFA and radiofrequency energy (RFA) in healthy and infarcted left ventricular (LV) myocardium in swine. METHODS Swine (n =10) underwent either: 1)120-minute left anterior descending coronary artery balloon occlusion myocardial infarction and survived for 6 to 8 weeks (n = 8); or 2) served as healthy control subjects (n = 2). PFA or RFA was delivered to the LV endocardium in regions of healthy myocardium or scar identified with electroanatomical mapping. Bipolar, biphasic PFA was delivered for 2.5 seconds x 4 applications/site using 2 different catheters: linear quadripolar (FOCAL) or multispline 8-pole catheter (BASKET). Gross and histologic measurements of lesion size were performed. RESULTS In the PFA group, 21 lesions were delivered to healthy LV and 20 to areas of scar. Overall, there was no significant difference in lesion depth between catheter groups (FOCAL linear vs BASKET; P = 0.740), whereas lesion width was greater for BASKET (10.6 +/- 2.4 mm vs 13.3 +/- 3.3 mm; P = 0.007). In myocardial scar, lesion depth was not significantly different between PFA catheters (P = 0.235). However, lesion depth for PFA was greater than for RFA (PFA vs RFA; 6.1 +/- 1.7 mm vs 3.8 +/- 1.7 mm; P = 0.005). CONCLUSIONS PFA allows rapid, safe, and effective ablation of surviving islands of myocardium within and around infarcted LV substrate. This technology holds promise for treating infarct-related ventricular tachycardia in humans. (C) 2022 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据